Home Overview Press Room Blog Publications For Students about us

Medical Gene Transfer : Displaying 86-95 of 137

Nature Biotech reports CGS skepticism about IRBs-for-hireby Marcy DarnovskyBiopolitical TimesFebruary 5th, 2008An article published in Nature Biotech last September quotes CGS's Osagie Obasogie's concerns about private IRBs.
The New Republic Asks Whether Baseball is Already Losing the Next Doping Battle by Osagie ObasogieBiopolitical TimesJanuary 29th, 2008The New Republic blog have shifted the focus of baseball's scrutiny from past to future by asking whether the sport is already losing the next big doping battle.
Boy gets leukaemia after gene treatment to cure ‘bubble baby syndrome’The Times (UK)December 19th, 2007One of the first children in Britain to receive gene therapy for an immune system disorder has developed leukaemia as a result of his treatment.
Death in gene therapy trial raises questions about private IRBsby Heidi LedfordNature BiotechnologySeptember 30th, 2007Researchers are increasingly turning to private, for-profit IRBs that promise quick turnaround times, especially for company-sponsored trials.
More Public Accountability Needed in Gene Therapy Death, Says Public Interest Group Center for Genetics and Society Calls for Moratorium on Enrolling Some PatientsSeptember 17th, 2007The Recombinant DNA Advisory Committee met today to discuss a recent death in an experiment, but offered no answers to important ethical questions raised by the tragedy.
Picking Nits or Learning Lessons?Defensiveness on Display in Gene Therapy Death by Marcy Darnovsky and Osagie K. ObasogieBioethics Forum September 17th, 2007The full story of a recent death in a gene therapy clinical trial is still unfolding. But there's a fair amount we do know, and much of it is troubling. Some gene therapy insiders have tried to diminish its significance by characterizing it as an unfortunate aspect of medical progress.
Targeted Genetics consent documentResearch subject information and consent form Jolee Mohr, a 36-year-old Illinois resident, was given this 15-page document before participating in a gene therapy experiment. She died on July 24, 2007, shortly after her second injection with the gene transfer product.
Gene Therapy Death Raises Ethical Issuesby Marcy DarnovskySan Francisco ChronicleSeptember 13th, 2007The recent death of a research subject in a gene therapy clinical trial raises critical, and troubling, questions.
The Empire Strikes Backby Osagie Obasogie Biopolitical TimesAugust 28th, 2007One would hope and expect that Jolee Mohr’s recent death during a gene therapy clinical trial would give pause to the field’s researchers as well as the multi-billion dollar clinical trial industry. But the response has been surprisingly defiant.
Fungus Infected Woman Who Died After Gene Therapyby Rick WeissWashington PostAugust 20th, 2007The 36-year-old Illinois woman who died last month after being treated with an experimental gene therapy was infected with a fungus that usually causes only a mild illness.
Displaying 86-95 of 137  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760